REMEDIUM LIFECARE Financial Statement Analysis
|
||
|
The Revenues of REMEDIUM LIFECARE have increased by 692.74% YoY .
The Earnings Per Share (EPS) of REMEDIUM LIFECARE has decreased by -78.43 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
REMEDIUM LIFECARE Last 5 Annual Financial Results
[BOM: 539561]
| Standalone | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹4,042 Cr | ₹510 Cr | ₹505 Cr | ₹90 Cr | ₹2.89 Cr |
| Expenses | ₹4,008 Cr | ₹503 Cr | ₹503 Cr | ₹89 Cr | ₹2.50 Cr |
| Operating Profit (Excl OI) | ₹34 Cr | ₹7.17 Cr | ₹1.82 Cr | ₹0.72 Cr | ₹0.39 Cr |
| Other Income | ₹21 Cr | ₹0.83 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr |
| Interest | ₹4.78 Cr | ₹0.45 Cr | ₹0.23 Cr | ₹0.02 Cr | ₹0.01 Cr |
| Depreciation | ₹0.06 Cr | ₹0.15 Cr | ₹0.07 Cr | ₹0.06 Cr | ₹0.01 Cr |
| Profit Before Tax | ₹50 Cr | ₹7.40 Cr | ₹1.53 Cr | ₹0.65 Cr | ₹0.38 Cr |
| Profit After Tax | ₹33 Cr | ₹5.43 Cr | ₹1.08 Cr | ₹0.48 Cr | ₹0.28 Cr |
| Earnings Per Share (Rs) | ₹3.25 | ₹15.07 | ₹2.99 | ₹1.33 | ₹0.77 |
| PAT Margin (%) | 0.81 | 1.06 | 0.21 | 0.53 | 9.58 |
| ROE(%) | 122.76 | 70.92 | 24.51 | 13.33 | 8.62 |
| ROCE(%) | 99.51 | 102.54 | 18.16 | 7.39 | 11.16 |
| Total Debt/Equity(x) | 1.34 | 0.00 | 0.00 | 2.72 | 0.11 |
Key Financials |
||
| Market Cap | : | ₹ 220.6 Cr |
| Revenue (TTM) | : | ₹ 3,345.5 Cr |
| Net Profit(TTM) | : | ₹ 18.5 Cr |
| EPS (TTM) | : | ₹ 0.5 |
| P/E (TTM) | : | 11.9 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| REMEDIUM LIFECARE | -0.6% | -18.6% | -80.2% |
| ADANI ENTERPRISES | -2.7% | -16.2% | -14.6% |
| REDINGTON | 3.5% | 11.9% | 22.5% |
| HONASA CONSUMER | -5% | -31.9% | -34.6% |
| MMTC | 1.2% | 3.4% | 47.7% |
| MSTC | 1.4% | 21.7% | 74% |
| LLOYDS ENTERPRISES | -0.7% | 1.3% | 7.7% |
| VERITAS (INDIA) | -2.1% | -3.8% | 133.3% |
| NOVARTIS INDIA | -4.1% | -6.2% | 45.1% |
REMEDIUM LIFECARE Revenues
[BOM: 539561]
| Y-o-Y | 692.74 % |
| 5 Yr CAGR | 511.53 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹4,042 Cr | 692.74 | |
| Mar2023 | ₹510 Cr | 1.00 | |
| Mar2022 | ₹505 Cr | 460.67 | |
| Mar2021 | ₹90 Cr | 3,015.36 | |
| Mar2020 | ₹2.89 Cr | - | |
REMEDIUM LIFECARE Operating Profit
[BOM: 539561]
| Y-o-Y | 376.96 % |
| 5 Yr CAGR | 206.39 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹34 Cr | 376.96 | |
| Mar2023 | ₹7.17 Cr | 294.99 | |
| Mar2022 | ₹1.82 Cr | 151.04 | |
| Mar2021 | ₹0.72 Cr | 86.34 | |
| Mar2020 | ₹0.39 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -39.72 % |
| 5 Yr CAGR | -49.84 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 0.85% | -39.72 | |
| Mar2023 | 1.41% | 291.67 | |
| Mar2022 | 0.36% | -55.00 | |
| Mar2021 | 0.8% | -94.04 | |
| Mar2020 | 13.43% | - | |
REMEDIUM LIFECARE Profit After Tax
[BOM: 539561]
| Y-o-Y | 503.21 % |
| 5 Yr CAGR | 229.70 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹33 Cr | 503.21 | |
| Mar2023 | ₹5.43 Cr | 403.34 | |
| Mar2022 | ₹1.08 Cr | 124.12 | |
| Mar2021 | ₹0.48 Cr | 73.65 | |
| Mar2020 | ₹0.28 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -23.58 % |
| 5 Yr CAGR | -46.08 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 0.81 % | -23.58 | |
| Mar2023 | 1.06 % | 404.76 | |
| Mar2022 | 0.21 % | -60.38 | |
| Mar2021 | 0.53 % | -94.47 | |
| Mar2020 | 9.58 % | - | |
REMEDIUM LIFECARE Earnings Per Share (EPS)
[BOM: 539561]
| Y-o-Y | -78.43 % |
| 5 Yr CAGR | 43.33 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹3.25 | -78.43 | |
| Mar2023 | ₹15 | 404.01 | |
| Mar2022 | ₹2.99 | 124.81 | |
| Mar2021 | ₹1.33 | 72.73 | |
| Mar2020 | ₹0.77 | - | |
REMEDIUM LIFECARE Return on Capital Employed (ROCE)
[BOM: 539561]
| Y-o-Y | -2.95 % |
| 5 Yr CAGR | 72.80 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 99.51% | -2.95 | |
| Mar2023 | 102.54% | 464.65 | |
| Mar2022 | 18.16% | 145.74 | |
| Mar2021 | 7.39% | -33.78 | |
| Mar2020 | 11.16% | - | |
REMEDIUM LIFECARE Share Price vs Sensex
| Current Share Price | : | ₹5.5 |
| Current MarketCap | : | ₹ 220.6 Cr |
| Updated EOD on | : | Dec 11,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| REMEDIUM LIFECARE | -0.6% |
-18.6% |
-80.2% |
| SENSEX | 0.7% |
2.5% |
17% |
REMEDIUM LIFECARE related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about REMEDIUM LIFECARE Financials
How the annual revenues of REMEDIUM LIFECARE have changed ?
The Revenues of REMEDIUM LIFECARE have increased by 692.74% YoY .
How the Earnings per Share (EPS) of REMEDIUM LIFECARE have changed?
The Earnings Per Share (EPS) of REMEDIUM LIFECARE has decreased by -78.43 % YoY .
Check out Intrinsic Value of Peers of REMEDIUM LIFECARE
|
Intrinsic Value of ADANI ENTERPRISES LTD Intrinsic Value of REDINGTON LTD Intrinsic Value of HONASA CONSUMER LTD Intrinsic Value of MMTC LTD Intrinsic Value of MSTC LTD |
Compare Stock Analytics of Peers of REMEDIUM LIFECARE
ADANI ENTERPRISES LTD vs REDINGTON LTD vs HONASA CONSUMER LTD
MMTC LTD vs MSTC LTD vs
ADANI ENTERPRISES LTD vs REDINGTON LTD vs HONASA CONSUMER LTD
MMTC LTD vs MSTC LTD vs
